ALA 1.43% 17.3¢ arovella therapeutics limited

Pfizer OTC, page-46

  1. 571 Posts.
    lightbulb Created with Sketch. 41
    Doole:
    Yr points r taken positively.
    Pfizer aren't handing out "research grants", which makes the process sound a little routine.
    I believe the OTC/003 co operative trials being conducted are more advanced than yr assumption of a casual, run of the mill trial of a new technology( the Oromist IP). If Pfizer find this new drug delivery technology to be proven and still improveable then they may have a new, advanced method of drug delivery to add to there clinical reportoire?
    This could be used in numerous Pfizer OTC/ pharmaceuticals. And at a potentially very competitive valuation.

    It's the patented hydrptrope technology that is what pharma companies are after.
    They need to do their own trials on someone else's technology.
    If Pfizer don't want it then some other company might, but I doubt that scenario!!
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
(20min delay)
Last
17.3¢
Change
-0.003(1.43%)
Mkt cap ! $183.9M
Open High Low Value Volume
17.0¢ 17.5¢ 16.8¢ $152.2K 892.2K

Buyers (Bids)

No. Vol. Price($)
2 145288 17.0¢
 

Sellers (Offers)

Price($) Vol. No.
17.5¢ 403577 12
View Market Depth
Last trade - 13.59pm 24/07/2024 (20 minute delay) ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.